|
[1]Fire A, Xu S, Montgomery MK, et al.Potent and specific geneticinterference by double-stranded RNA in Caenorhabditis elegans[J].Nature, 1998, 391∶806.
|
|
[2] Tabara H, Grysbok A, Mello CC.RNAi in C.elegans:soaking inthe genome sequence[J].Science, 1998, 282∶430.
|
|
[3] Fraser AG, Kamath RS, Zipperlen P, et al.Functional genomic a-nalysis of C.elegans chronic some by systematicRNA interference[J].Nature, 2000, 408∶325.
|
|
[4]Shirane D, Sugao K, Namiki S, et al.Enzymatic production ofRNAi libraries from cDNAs[J].Nature Genet, 2004, 36∶190.
|
|
[5]Sato Y, Ajiki T, Inoue S, et al.Gene silencing in rat-liver andlimb grafts by rapid injection of small interference RNA[J].Trans-plantation, 2005, 79∶240.
|
|
[6]Layzer JM, Mccaffrey AP, Tanner AK, et al.in vivo activity of nu-clease-resistant siRNAs[J].RNA, 2004, 10 (5) ∶766-771.
|
|
[7]Soler M, Pellerin M, Malnou C E, et al.RNAi species heterogeneityand constraints on the evolution of 5 noncoding region of HCV rela-tionship with HCV resistance to therapy[J].Virology, 2002, 298∶160.
|
|
[8]项红军.RNAi对肝癌细胞腺苷受体A2b-mRNA抑制的实验研究[J].中华普通外科杂志, 2005, 8∶529.
|
|
[9]曹晓哲, 朱明华, 祝峙, 等.RNA干扰p53对肝细胞癌SK-Hep-1细胞细胞周期的影响[J].中国体视学与图像分析, 2005, 10∶6.
|
|
[10]卢小东, 覃文新, 潘东宁, 等.DNA载体途径的RNA干扰技术对肝癌细胞系HCCLM3端粒酶活性的抑制作用[J].中华医学杂志, 2004, 8 (17) ∶1381.
|
|
[11]闫歌, 蒲丹, 唐霓, 等.RNA干扰技术对肝癌细胞内源survivin基因表达的影响[J].生物化学与生物物理进展, 2004, 31 (9) ∶829.
|
|
[12]王宝恩.大鼠结缔组织生长因子部分cDNA序列的克隆及mR-NA在实验性肝纤维化中的表达[J].中华肝脏病杂志, 2000, 8 (2) ∶102.
|
|
[13]Derynck R, Feng X H.TGF-βreceptor signaling[J].Bio chembiographys, 1997, 1333∶F105.
|
|
[14]李光明, 谢青, 史毅, 等.siRNA对HSC结缔组织生长因子的抑制作用[J].上海第二医科大学学报, 2005, 25 (2) ∶116.
|
|
[15]Kanzler S, Lohse AW, Weil A, et al.TGF-betal in liver fibrosis:an inducible transgenic mouse model to study liver fibrogenesis[J].Am J Physiol, 1999, 276 (4) ∶1059.
|
|
[16]Heldin C H, M iyazono K, ten D ijke P.TGF-βsignaling fromcell membrane to nucleus through SMAD proteins[J].Nature, 1997, 8∶213.
|
|
[17]Blom IE, Goldschmeding R, Leask A.Gene regulation of connec-tive tissue growth factor:new targets for antifibrotic therapy[J].Ma-trix Biol, 2002, 21∶473.
|
|
[18]Rachfal AW, Brigstock DR.Connective tissue growth factor (CT-GF/CCN2) in hepatic fibrosis[J].Hepatol Res, 2003, 26∶1.
|
|
[19]Yu JY, Taylor J, DeRuiter SL, et al.Simultaneous inhibition ofGSK3alpha and GSK3betal using hairpin siRNA expression vectors[J].Matrix Biol, 2003, 7 (2) ∶228.
|
PDF下载 ( 175 KB)
本文二维码
下载:
